PT - JOURNAL ARTICLE AU - Walshe, Nicola AU - Fennelly, Mehael AU - Hellebust, Stig AU - Wenger, John AU - Sodeau, John AU - Prentice, Michael AU - Grice, Charlene AU - Jordan, Vincent AU - Comerford, John AU - Downey, Vicky AU - Perrotta, Carla AU - Mulcahy, Grace AU - Sammin, Donal TI - Assessment of Environmental and Occupational Risk Factors for the Mitigation and Containment of a COVID-19 Outbreak in a Meat Processing Plant AID - 10.1101/2021.09.17.21262959 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.17.21262959 4099 - http://medrxiv.org/content/early/2021/09/21/2021.09.17.21262959.1.short 4100 - http://medrxiv.org/content/early/2021/09/21/2021.09.17.21262959.1.full AB - Throughout the COVID-19 pandemic, meat processing plants have been vulnerable to outbreaks of SARS-CoV-2 infection. Transmission of the virus is difficult to control in these settings because of a combination of factors including environmental conditions and the specific nature of the work. This paper describes a retrospective outbreak investigation in a meat processing plant, a description of the measures taken to prevent or contain further outbreaks, and insights on how those with specific knowledge of the working environment of these plants can collaborate with public health authorities to ensure optimal outbreak control. The plant experienced 111 confirmed positive asymptomatic cases in total with an estimated attack rate of 38% during a five-week period. Four weeks after the first case, mass screening of all workers was conducted by the public health authorities. Thirty-two workers tested positive, of which 16 (50%) worked in one particular area of the plant, the boning hall (n=60). The research team prepared and carried out semi-structured interviews with the plant personnel who were charged with COVID control within the plant. They carried out assessments of operational risk factors and also undertook air quality monitoring in the boning hall and abattoir. The air quality measurements in the boning hall showed a gradual build-up of carbon dioxide and aerosol particles over the course of a work shift, confirming that this poorly ventilated area of the plant had an environment that was highly favourable for aerosol transmission of SARS-CoV-2. Assessment of operational conditions incorporated visual surveys of the plant during the working day. Prior to and during the first two weeks of the outbreak, multiple measures were introduced into the plant by management, including physical distancing, provision of educational material to workers, visitor restrictions, and environmental monitoring. After the implementation of these measures and their progressive refinement by plant management, the factory had no further linked cases (clusters) or outbreaks for the following 198 days. The tailored approach to risk mitigation adopted in this meat processing plant shows that generic risk mitigation measures, as recommended by public health authorities, can be successfully adapted and optimized by designated plant emergency response teams.Competing Interest StatementThe authors have declared no competing interest.Funding StatementInitial funding for the Pilot Study was provided by DAFM. The work is further supported by COVID Rapid Response grant 20/COV/8436 from Science Foundation Ireland. None of the authors or their institutions at any time received any other payment or services from any third party for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UCD Human Research Ethics Committee provided Exemption from full review - reference number LS-E-20-196-Mulcahy).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data files are maintained in encrypted form by the project consortium and are available on request from the authors